Protective Roles of Adipocytokines and Myokines in Cardiovascular Disease.

Obesity is a major risk factor for progression of cardiovascular disease. Adipose tissue is recognized as an endocrine organ producing various secretory molecules, also known as adipocytokines, and dysregulated production of adipocytokines participates in the pathogenesis of obesity complications, including metabolic dysfunction and cardiovascular disorders. Recent evidence indicates that skeletal muscle also functions as an endocrine organ capable of secreting a number of bioactive substances, also referred to as myokines. Several myokines are involved in metabolic and cardiovascular regulation. This review will discuss the clinical and experimental studies that have investigated the protective role of several adipocytokines and myokines in cardiovascular diseases. (Circ J 2016; 80: 2073-2080).

[1]  F. Recchia,et al.  Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture , 2016, EMBO molecular medicine.

[2]  T. Murohara,et al.  Association of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy Men , 2016, PloS one.

[3]  S. Kihara,et al.  Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. , 2016, Cardiovascular research.

[4]  A. Jaffe,et al.  C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery. , 2016, The Journal of clinical endocrinology and metabolism.

[5]  M. Schulze,et al.  Omentin-1, Adiponectin, and the Risk of Developing Type 2 Diabetes , 2016, Diabetes Care.

[6]  Youichi Kobayashi,et al.  Counteractive effects of omentin-1 against atherogenesis†. , 2016, Cardiovascular research.

[7]  J. Park,et al.  C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells , 2016, Molecular and Cellular Endocrinology.

[8]  Sungha Park,et al.  Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. , 2015, Atherosclerosis.

[9]  Bin Zhou,et al.  Epicardial FSTL1 reconstitution regenerates the adult mammalian heart , 2015, Nature.

[10]  G. Kottas,et al.  Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY , 2015, Journal of cardiovascular medicine.

[11]  T. Murohara,et al.  C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism , 2015, Molecular and Cellular Biology.

[12]  H. Tschan,et al.  Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women , 2015, Experimental Gerontology.

[13]  W. Rathmann,et al.  Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. , 2015, European journal of endocrinology.

[14]  P. Zhang,et al.  CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages. , 2015, Biochemical and biophysical research communications.

[15]  T. Murohara,et al.  Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model. , 2015, Journal of the American Society of Nephrology : JASN.

[16]  K. Awai,et al.  Association of epicardial and abdominal visceral adipose tissue with coronary atherosclerosis in patients with a coronary artery calcium score of zero. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[17]  S. Kihara,et al.  Omentin functions to attenuate cardiac hypertrophic response. , 2015, Journal of molecular and cellular cardiology.

[18]  T. Murohara,et al.  Adipose‐derived protein omentin prevents neointimal formation after arterial injury , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  I. Shimomura,et al.  Targeted delivery of adipocytokines into the heart by induced adipocyte cell-sheet transplantation yields immune tolerance and functional recovery in autoimmune-associated myocarditis in rats. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[20]  ReiShibata,et al.  Neuron-Derived Neurotrophic Factor Ameliorates Adverse Cardiac Remodeling After Experimental Myocardial Infarction , 2015 .

[21]  H. Yatsuya,et al.  Global trend in overweight and obesity and its association with cardiovascular disease incidence. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[22]  H. Oflaz,et al.  Serum Omentin 1 Level Is Associated With Coronary Artery Disease and Its Severity in Postmenopausal Women , 2014, Angiology.

[23]  Y. Hwang,et al.  Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans , 2014, International Journal of Obesity.

[24]  J. Park,et al.  Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes. , 2014, The Journal of clinical endocrinology and metabolism.

[25]  T. Murohara,et al.  Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury. , 2014, Cardiovascular research.

[26]  T. Murohara,et al.  Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. , 2014, Journal of the American College of Cardiology.

[27]  M. Okada,et al.  A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through antioxidative mechanism. , 2014, American journal of physiology. Heart and circulatory physiology.

[28]  Sungeun Kim,et al.  Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. , 2014, The Journal of clinical endocrinology and metabolism.

[29]  I. Kubota,et al.  Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure , 2014, Cardiovascular Diabetology.

[30]  T. Murohara,et al.  Neuron-derived Neurotrophic Factor Functions as a Novel Modulator That Enhances Endothelial Cell Function and Revascularization Processes* , 2014, The Journal of Biological Chemistry.

[31]  G. W. Wong,et al.  Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice. , 2014, American journal of physiology. Endocrinology and metabolism.

[32]  T. Murohara,et al.  Transcriptional Regulation of an Insulin-Sensitizing Adipokine Adipolin/CTRP12 in Adipocytes by Krüppel-Like Factor 15 , 2013, PloS one.

[33]  M. Matsuzaki,et al.  Impact of Physical Activity on Cardiovascular Events in Patients With Chronic Heart Failure , 2013 .

[34]  R. Abbott,et al.  Epidemiology of cardiovascular risk factors in Asian countries. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[35]  M. Matsuzaki,et al.  Impact of physical activity on cardiovascular events in patients with chronic heart failure. A multicenter prospective cohort study. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[36]  Yajing Wang,et al.  C1q/Tumor Necrosis Factor–Related Protein-9, a Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling in the Ischemic Mouse Heart via Protein Kinase A Activation , 2013, Circulation.

[37]  M. Seldin,et al.  CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[38]  N. Turner,et al.  Loss of Krüppel-Like Factor 3 (KLF3/BKLF) Leads to Upregulation of the Insulin-Sensitizing Factor Adipolin (FAM132A/CTRP12/C1qdc2) , 2013, Diabetes.

[39]  Tetsuya Ohira,et al.  Cardiovascular disease epidemiology in Asia: an overview. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[40]  J. Eckel,et al.  Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells , 2013, Archives of physiology and biochemistry.

[41]  Noriteru Morita,et al.  Is gender a factor in the reduction of cardiovascular risks with exercise training? , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[42]  T. Murohara,et al.  Adipose‐derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  T. Murohara,et al.  Regulation of adipolin/CTRP12 cleavage by obesity. , 2012, Biochemical and biophysical research communications.

[44]  T. Murohara,et al.  Therapeutic Impact of Follistatin-Like 1 on Myocardial Ischemic Injury in Preclinical Models , 2012, Circulation.

[45]  M. Seldin,et al.  Endopeptidase Cleavage Generates a Functionally Distinct Isoform of C1q/Tumor Necrosis Factor-related Protein-12 (CTRP12) with an Altered Oligomeric State and Signaling Specificity* , 2012, The Journal of Biological Chemistry.

[46]  S. Kihara,et al.  Omentin as a novel biomarker of metabolic risk factors , 2012, Diabetology & Metabolic Syndrome.

[47]  T. Murohara,et al.  CTRP9 Protein Protects against Myocardial Injury following Ischemia-Reperfusion through AMP-activated Protein Kinase (AMPK)-dependent Mechanism* , 2012, The Journal of Biological Chemistry.

[48]  L. Cebotaru,et al.  C1q/TNF-related Protein-12 (CTRP12), a Novel Adipokine That Improves Insulin Sensitivity and Glycemic Control in Mouse Models of Obesity and Diabetes* , 2012, The Journal of Biological Chemistry.

[49]  B. Spiegelman,et al.  A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.

[50]  M. Obin.  Adipose Tissue Remodeling and Metabolically Healthy Obesity , 2012 .

[51]  Shingo,et al.  A PGC1-\(\alpha\)-dependent Myokine that Drives Brown-fat-like Development of White Fat and Thermogenesis , 2012 .

[52]  Yajing Wang,et al.  Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNFα-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice , 2012, Basic Research in Cardiology.

[53]  S. Kihara,et al.  Circulating omentin is associated with coronary artery disease in men. , 2011, Atherosclerosis.

[54]  S. Kihara,et al.  Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men , 2011, Hypertension Research.

[55]  Qiang-sun Zheng,et al.  Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[56]  S. Kihara,et al.  Fat-derived Factor Omentin Stimulates Endothelial Cell Function and Ischemia-induced Revascularization via Endothelial Nitric Oxide Synthase-dependent Mechanism* , 2011, The Journal of Biological Chemistry.

[57]  Yajing Wang,et al.  C1q/TNF-Related Proteins, A Family of Novel Adipokines, Induce Vascular Relaxation Through the Adiponectin Receptor-1/AMPK/eNOS/Nitric Oxide Signaling Pathway , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[58]  Kazuto Nakamura,et al.  Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload , 2011, Proceedings of the National Academy of Sciences.

[59]  K. Walsh,et al.  Follistatin-Like 1 in Chronic Systolic Heart Failure: A Marker of Left Ventricular Remodeling , 2011, Circulation. Heart failure.

[60]  T. Murohara,et al.  Adipolin/C1qdc2/CTRP12 Protein Functions as an Adipokine That Improves Glucose Metabolism* , 2011, The Journal of Biological Chemistry.

[61]  F. Gilbert,et al.  Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[62]  M. Okada,et al.  Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. , 2011, Biochemical and biophysical research communications.

[63]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[64]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[65]  J. Ribeiro,et al.  Physical Activity Advice Only or Structured Exercise Training and Association With HbA 1 c Levels in Type 2 Diabetes , 2011 .

[66]  Xiu-Li Kuang,et al.  Spatio-temporal expression of a novel neuron-derived neurotrophic factor (NDNF) in mouse brains during development , 2010, BMC Neuroscience.

[67]  Qiang Li,et al.  Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. , 2010, Diabetes research and clinical practice.

[68]  M. Okada,et al.  Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. , 2010, Biochemical and biophysical research communications.

[69]  B. Fernhall,et al.  Resistance exercise training reduces central blood pressure and improves microvascular function in African American and white men. , 2009, Atherosclerosis.

[70]  H. Katus,et al.  Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. , 2009, Clinical chemistry.

[71]  H. Lodish,et al.  Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  K. Walsh,et al.  Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism* , 2008, Journal of Biological Chemistry.

[73]  J. Gehl,et al.  Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. , 2008, The Journal of clinical endocrinology and metabolism.

[74]  K. Walsh,et al.  Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart , 2008, Circulation.

[75]  B. Pedersen,et al.  Expression of interleukin‐15 in human skeletal muscle – effect of exercise and muscle fibre type composition , 2007, The Journal of physiology.

[76]  A. Shuldiner,et al.  Omentin Plasma Levels and Gene Expression Are Decreased in Obesity , 2007, Diabetes.

[77]  B. Pedersen,et al.  Beneficial health effects of exercise--the role of IL-6 as a myokine. , 2007, Trends in pharmacological sciences.

[78]  A. Shuldiner,et al.  Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. , 2006, American journal of physiology. Endocrinology and metabolism.

[79]  Hirofumi Tanaka,et al.  Resistance Training Increases Basal Limb Blood Flow and Vascular Conductance in Aging Humans , 2006, Journal of applied physiology.

[80]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[81]  Se-Jin Lee,et al.  Suppression of body fat accumulation in myostatin-deficient mice. , 2002, The Journal of clinical investigation.

[82]  K. Yarasheski,et al.  Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. , 2002, The journal of nutrition, health & aging.

[83]  K. Toyoshima,et al.  Human Intelectin Is a Novel Soluble Lectin That Recognizes Galactofuranose in Carbohydrate Chains of Bacterial Cell Wall* , 2001, The Journal of Biological Chemistry.

[84]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[85]  B. J. Murawaski.  Dialysis patients. , 1980, Psychosomatic medicine.